{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T19:50:45Z","timestamp":1760644245873},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1006\/niox.1999.0261","type":"journal-article","created":{"date-parts":[[2002,10,7]],"date-time":"2002-10-07T14:29:07Z","timestamp":1034000947000},"page":"454-458","source":"Crossref","is-referenced-by-count":29,"title":["Nitric Oxide Production Is Increased in Patients with Inflammatory Myositis"],"prefix":"10.1006","volume":"3","author":[{"given":"A.","family":"Wanchu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Khullar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bambery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/niox.1999.0261_RF1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","article-title":"Myositis: Immunologic contribution to understanding cause, pathogenesis and therapy","volume":"122","author":"Plotz","year":"1995","journal-title":"Ann. Int. Med."},{"key":"10.1006\/niox.1999.0261_RF2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1997","journal-title":"Medicine"},{"key":"10.1006\/niox.1999.0261_RF3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.7326\/0003-4819-111-2-143","article-title":"Current concepts in the idiopathic inflammatory myopathies, polymyositis, dermatomyositis and related disorders","volume":"111","author":"Plotz","year":"1998","journal-title":"Ann. Int. Med."},{"key":"10.1006\/niox.1999.0261_RF4","unstructured":"Wortmann, R. L.1997. Inflammatory diseases of muscle and other myopathies. InTextbook of Rheumatology (W. N. Kelly, S. Ruddy, E. D. Harris, and C. B. Sledge, Eds.), 5th ed., pp. 1177\u20131206. Saunders, Philadelphia."},{"key":"10.1006\/niox.1999.0261_RF5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/jcp.43.11.893","article-title":"Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue","volume":"43","author":"Smith","year":"1990","journal-title":"J. Clin. Pathol."},{"key":"10.1006\/niox.1999.0261_RF6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(85)91384-4","article-title":"Increased expression of HLA A, B, C class I antigen by muscle fibres in Duchenne muscular dystrophy, inflammatory myopathy and other neuromuscular disorders","volume":"1","author":"Appleyard","year":"1985","journal-title":"Lancet"},{"key":"10.1006\/niox.1999.0261_RF7","first-page":"129A","article-title":"Cytotoxic effect of interferon gamma (IFN-\u03b3) and tissue necrosis factor-alpha (TNF\u03b1) on human muscle cells","volume":"150","author":"Kalaovidowris","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/niox.1999.0261_RF8","first-page":"G1499","article-title":"Transcriptional regulation of human inducible nitrite oxide synthase gene in an intestinal epithelial liver","volume":"272","author":"Linn","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1006\/niox.1999.0261_RF9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1073\/pnas.93.3.1054","article-title":"Transcription regulation of human inducible nitrite oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter","volume":"93","author":"DeVera","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/niox.1999.0261_RF10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00001756-199612200-00031","article-title":"Increase of nitrite oxide synthases and nitrotyrosine in inclusion body myositis","volume":"8","author":"Yang","year":"1996","journal-title":"Neuroreport"},{"key":"10.1006\/niox.1999.0261_RF11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","article-title":"Nitrite oxide in physiologic messenger molecule","volume":"63","author":"Bredt","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1006\/niox.1999.0261_RF12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF02918387","article-title":"Elevated urinary nitrite and citrulline levels in patients with rheumatoid arthritis","volume":"7","author":"Wanchu","year":"1999","journal-title":"Inflamopharmacology"},{"key":"10.1006\/niox.1999.0261_RF13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002960050055","article-title":"Increased concentration of nitrite and citrulline in serum samples suggest active disease in systemic Lupus erythematosus","volume":"18","author":"Wanchu","year":"1998","journal-title":"Rheumatol. Int."},{"key":"10.1006\/niox.1999.0261_RF14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Eng. J. Med."},{"key":"10.1006\/niox.1999.0261_RF15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite and (15N) nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Ann. Biochem."},{"key":"10.1006\/niox.1999.0261_RF16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0003-2697(80)90404-2","article-title":"Optimization of conditions for the calorimetric determination of citrulline, using diacetyl monoxime","volume":"107","author":"Boyde","year":"1980","journal-title":"Ann. Biochem."},{"key":"10.1006\/niox.1999.0261_RF17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2249.1998.00648.x","article-title":"Inducible nitric oxide synthase in human disease","volume":"113","author":"Kroncke","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/niox.1999.0261_RF18","first-page":"4391","article-title":"Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice","volume":"55","author":"Tamir","year":"1995","journal-title":"Cancer Res."},{"key":"10.1006\/niox.1999.0261_RF19","first-page":"1823","article-title":"Nitrotyrosine formation, apoptosis, and oxidative damage: Relationships to nitric oxide production in SJL mice bearing the RcsX tumor","volume":"57","author":"Gal","year":"1997","journal-title":"Cancer Res."},{"key":"10.1006\/niox.1999.0261_RF20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/ard.56.5.330","article-title":"Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity","volume":"56","author":"Wigand","year":"1997","journal-title":"Ann. Rheum. Dis."},{"key":"10.1006\/niox.1999.0261_RF21","doi-asserted-by":"crossref","first-page":"10043","DOI":"10.1073\/pnas.87.24.10043","article-title":"Glucocorticoids inhibit expression of an inducible, but not constitutive nitric oxide synthase in the vascular endothelium","volume":"87","author":"Radomaski","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/niox.1999.0261_RF22","unstructured":"Voet, D., and Voet, J. G.1995. Amino acid metabolism. InBiochemistry (D. Voet and J. G. Voet, Eds.), 2nd ed., pp. 732\u2013734. Wiley, New York."},{"key":"10.1006\/niox.1999.0261_RF23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/niox.1997.0162","article-title":"Nonenzymatic nitric oxide production in humans","volume":"2","author":"Weitzberg","year":"1998","journal-title":"Nitric Oxide: Biol. Chem."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860399902616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860399902616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T21:50:13Z","timestamp":1557265813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860399902616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["S1089860399902616"],"URL":"https:\/\/doi.org\/10.1006\/niox.1999.0261","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}